Pular para o conteúdo
Nefroma mesoblástico congênito
ORPHA:2665CID-10 · D41.0CID-11 · 2C90.YDOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
Início neonatal

Neoplasia maligna congênita infantil de baixo grau que surge do rim. É caracterizada pela presença de células fibroblásticas. A maioria dos casos ocorre no primeiro ano de vida. A excisão completa geralmente está associada a um excelente prognóstico.

Última verificação: Fonte: sem afirmação sobre o SUS a verificarEm construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

O nefroma mesoblástico congênito é um tumor raro originado no rim, de baixo grau, que se desenvolve principalmente em bebês e crianças no primeiro ano de vida. Ele é caracterizado pela presença de células de formato fibroblástico e sua manifestação ocorre de forma congênita ou neonatal. A retirada cirúrgica completa do tumor é o caminho habitual e costuma garantir um excelente prognóstico para o bebê. No Brasil, a condição não consta na lista oficial de Protocolos Clínicos e Diretrizes Terapêuticas (PCDT) de doenças raras do Ministério da Saúde, sendo o cuidado conduzido pela rede hospitalar do SUS.

Informacoes curadas por IA — podem conter imprecisoes
[1] Orphanet [18] Ministério da Saúde — lista oficial de…
📋
Informacoes curadas por IA — podem conter imprecisoes

Neoplasia maligna congênita infantil de baixo grau que surge do rim. É caracterizada pela presença de células fibroblásticas. A maioria dos casos ocorre no primeiro ano de vida. A excisão completa geralmente está associada a um excelente prognóstico.

Pesquisas ativas
2 ensaios
6 total registrados no ClinicalTrials.gov
Publicações científicas
406 artigos
Último publicado: 2026 Feb 28
🏥
SUS: Sem cobertura SUSScore: 20%
CID-10: D41.0
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico406PubMed
Últimos 10 anos126publicações
Pico202117 papers
Linha do tempo
2026Hoje · 2026🧪 2007Primeiro ensaio clínico📈 2021Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

2 genes identificados com associação a esta condição.

ETV6Transcription factor ETV6Part of a fusion gene inAltamente restrito
VIAS BIOLÓGICAS (1)
Signaling by FLT3 fusion proteins
EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
45.0 TPM
Glândula salivar
42.7 TPM
Skin Sun Exposed Lower leg
35.5 TPM
Linfócitos
30.0 TPM
Aorta
29.4 TPM
OUTRAS DOENÇAS (9)
acute myeloid leukemiathrombocytopenia 5B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1)obsolete autosomal thrombocytopenia with normal platelets
HGNC:3495UniProt:P41212
NTRK3NT-3 growth factor receptorPart of a fusion gene inAltamente restrito
VIAS BIOLÓGICAS (4)
NTF3 activates NTRK3 signalingSignaling by NTRK3 (TRKC)NTRK3 as a dependence receptorReceptor-type tyrosine-protein phosphatases
EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
32.5 TPM
Artéria coronária
22.1 TPM
Aorta
21.6 TPM
Cerebelo
15.8 TPM
Cérebro - Hemisfério cerebelar
13.9 TPM
OUTRAS DOENÇAS (3)
congenital mesoblastic nephromadifferentiated thyroid carcinomafibrosarcoma
HGNC:8033UniProt:Q16288

Variantes genéticas (ClinVar)

218 variantes patogênicas registradas no ClinVar.

🧬 NTRK3: GRCh37/hg19 15q24.1-26.3(chr15:73506509-102429112)x3 ()
🧬 NTRK3: GRCh37/hg19 15q24.1-26.3(chr15:75165490-102520892)x3 ()
🧬 NTRK3: GRCh37/hg19 15q25.2-26.3(chr15:84228005-102264590)x3 ()
🧬 NTRK3: GRCh37/hg19 15q22.33-26.1(chr15:67358491-91644328)x3 ()
🧬 NTRK3: GRCh37/hg19 15q24.3-26.3(chr15:77512817-102035027)x3 ()
Ver todas no ClinVar

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Nefroma mesoblástico congênito

Centros de Referência SUS

24 centros habilitados pelo SUS para Nefroma mesoblástico congênito

Centros para Nefroma mesoblástico congênito

Detalhes dos centros

Hospital Universitário Prof. Edgard Santos (HUPES)

R. Dr. Augusto Viana, s/n - Canela, Salvador - BA, 40110-060 · CNES 0003808

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFG

Rua 235 QD. 68 Lote Área, Nº 285, s/nº - Setor Leste Universitário, Goiânia - GO, 74605-050 · CNES 2338424

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Universitário da UFJF

R. Catulo Breviglieri, Bairro - s/n - Santa Catarina, Juiz de Fora - MG, 36036-110 · CNES 2297442

Atenção Especializada

Rota
Anomalias Congênitas

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Julio Müller (HUJM)

R. Luis Philippe Pereira Leite, s/n - Alvorada, Cuiabá - MT, 78048-902 · CNES 2726092

Atenção Especializada

Rota
Anomalias Congênitas

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Lauro Wanderley (HULW)

R. Tabeliao Estanislau Eloy, 585 - Castelo Branco, João Pessoa - PB, 58050-585 · CNES 0002470

Atenção Especializada

Rota
Anomalias Congênitas

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital Universitário Regional de Maringá (HUM)

Av. Mandacaru, 1590 - Parque das Laranjeiras, Maringá - PR, 87083-240 · CNES 2216108

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Pedro Ernesto (HUPE-UERJ)

Blvd. 28 de Setembro, 77 - Vila Isabel, Rio de Janeiro - RJ, 20551-030 · CNES 2280221

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital São Lucas da PUCRS

Av. Ipiranga, 6690 - Jardim Botânico, Porto Alegre - RS, 90610-000 · CNES 2232928

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário da UFSC (HU-UFSC)

R. Profa. Maria Flora Pausewang - Trindade, Florianópolis - SC, 88036-800 · CNES 2560356

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Base de São José do Rio Preto

Av. Brg. Faria Lima, 5544 - Vila Sao Jose, São José do Rio Preto - SP, 15090-000 · CNES 2079798

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

UNIFESP / Hospital São Paulo

R. Napoleão de Barros, 715 - Vila Clementino, São Paulo - SP, 04024-002 · CNES 2688689

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Onde estão os ensaios

Com ensaio aberto em 6 países. O ponto verde marca onde há vaga agora.

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

6 ensaios clínicos encontrados, 2 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

📖Melhor nível de evidência: Revisão
Timeline de publicações
128 papers (10 anos)
#1

Congenital mesoblastic nephroma: a single-center retrospective study.

Translational pediatrics2026 Feb 28

Congenital mesoblastic nephroma (CMN) is a rare renal tumor predominantly occurring in neonates and young infants, and standardized treatment guidelines remain lacking. This study aimed to summarize the clinical features, therapeutic strategies, and outcomes of CMN patients from a single institution to inform clinical practice. We retrospectively reviewed the medical records of nine children with pathologically and molecularly confirmed CMN treated at Children's Hospital of Nanjing Medical University between 2015 and 2024. Demographic characteristics, clinical presentation, imaging findings, histological subtypes, gene fusions, treatment approaches, and follow-up data were analyzed. The median age at diagnosis was 2.5 months (range: newborn to 93 months), with a male-to-female ratio of 2:1. Most patients (90%) presented with an abdominal mass detected prenatally or incidentally. The tumor originated from the right kidney in seven cases and the left in two. Ultrasound and computed tomography (CT) commonly revealed mixed cystic-solid masses, with heterogeneous enhancement on contrast imaging. Pathological subtypes included cellular (n=5), classic (n=2), and mixed (n=2). Of seven patients undergoing fluorescence in situ hybridization (FISH), three were positive for the ETV6::NTRK3 fusion; four were negative; and two relapsed patients underwent next-generation sequencing (NGS), which identified TPM3::NTRK1 and EGFR-kinase domain duplication (EGFR-KDD), respectively. All patients underwent surgical resection with a 100% resection rate. Two relapsed patients received salvage chemotherapy [vincristine-actinomycin D-cyclophosphamide (VAC) or ifosfamide-carboplatin-etoposide (ICE)], which showed limited efficacy. One relapsed patient with TPM3::NTRK1 received larotrectinib but died two months later; another with EGFR-KDD experienced disease stabilization after afatinib plus programmed cell death protein 1 (PD-1) blockade following progression on entrectinib and anlotinib. After a median follow-up of 36 months (range: 12-115 months), the overall survival was 88.9%, and the event-free survival was 77.8%. This small single-center case series describes the clinical and molecular heterogeneity of CMN. While most patients experienced favorable outcomes following surgery, relapsed cases highlight the challenges associated with molecularly atypical disease. These observations are descriptive in nature and underscore the need for larger collaborative studies to better define prognostic factors and optimal management strategies in CMN.

#2

Relapsed rhabdoid tumours and other non-nephroblastoma childhood and adolescent kidney tumours: perspectives from the HARMONICA collaboration.

Nature reviews. Urology2026 Jan 02

Paediatric kidney tumours are generally associated with a favourable survival rate. Most children are diagnosed with Wilms tumour, which has a 90% long-term survival rate with conventional front-line and salvage therapies. However, treatments and outcomes of children with relapsed non-Wilms tumours, such as malignant rhabdoid tumour of the kidney, renal-cell carcinoma (including renal medullary carcinoma), clear-cell sarcoma of the kidney, anaplastic sarcoma of the kidney and congenital mesoblastic nephroma are not well defined. Several of these non-Wilms tumours include unfavourable prognostic subtypes. Currently available data on non-Wilms tumours support advancing studies that pivot from conventional strategies towards disease-specific, biologically driven novel treatments to improve outcomes for each of these rare childhood kidney tumours.

#3

Neuroblastoma Presenting as a Congenital Renal Mass in a Neonate: A Diagnostic Pitfall.

Children (Basel, Switzerland)2026 Feb 19

Congenital renal masses in neonates are most commonly congenital mesoblastic nephroma or, less frequently, or Wilms tumor. We describe a neonate with an apparent primary renal tumor that proved to be adrenal neuroblastoma infiltrating the kidney, highlighting diagnostic pitfalls in this subgroup of patients. We retrospectively reviewed the diagnostic work-up, histopathology, genomic profiling, treatment, and outcome of a term neonate in whom a renal mass was detected incidentally on ultrasound. Ultrasound and MRI showed a 2 cm solid lesion centered in the upper pole of the left kidney, interpreted as nephroblastomatosis/early Wilms tumor. Left nephrectomy with adrenalectomy revealed stroma-poor, undifferentiated neuroblastoma with regional node involvement and multiple segmental chromosomal aberrations, including 1p and 3p loss, but no MYCN or ALK alterations. Initial management consisted of surgery alone with close surveillance. Within weeks, early disseminated relapse with bone and soft-tissue metastases occurred, necessitating escalation to high-risk, COJEC-based chemotherapy; resection of residual mass; and modified consolidation without high-dose chemotherapy or radiotherapy. The child remains in complete remission with preserved renal function. Neuroblastoma should be considered in the differential diagnosis of congenital "renal" masses. Imaging-driven provisional diagnoses may be misleading, and genomic risk profiling may help lower the threshold for systemic therapy in selected cases.

#4

[Pink-red discoloration in the diaper of a neonate].

Nederlands tijdschrift voor geneeskunde2026 Feb 23

Pink-red discoloration in the diaper of neonates is often attributed to harmless urate crystals, formed from uric acid. However, clinicians should remain alert to other possible causes of pink-red discoloration. Here we present two cases of pink-red discoloration in neonates: one due to a congenital mesoblastic nephroma and the other one due to renal vein thrombosis as underlying cause. Additional diagnostics should be considered at a low threshold, starting with a simple urine dipstick. If the dipstick is negative for haem, hematuria can be excluded. If positive, urine sediment analysis is the next step to differentiate between hematuria, myoglobinuria or hemoglobinuria. In case of persisting haem-negative pink-red discoloration or in case of hematuria, myoglobinuria or hemoglobinuria consultation with a pediatrician is recommended, as further diagnostic evaluation is recommended.

#5

Mesoblastic nephroma in a young Entlebucher Mountain Dog.

Journal of comparative pathology2026 Jan

An intact 16-month-old female Entlebucher Mountain Dog in poor general condition was presented with clinical signs of gastrointestinal disease. Abdominal ultrasonography revealed a mass in the right kidney. Nephrectomy combined with ovariohysterectomy was performed. Histology revealed a mesenchymal tumour that was composed of neoplastic spindle cells forming interlacing fascicles, whorls and bundles, and embedded into a loose myxoid to dense collagenous stroma. Immunohistochemically, neoplastic cells diffusely labelled for vimentin and partially for S-100 protein and p75NTR. Based on these results, the tumour was diagnosed as a classical variant of a congenital mesoblastic nephroma. The expression of p75NTR has not been described in this tumour entity before and its significance with regard to tumour promoting or tumour suppressing function or indication of a neurogenic differentiation remains undetermined. After a 3-year follow-up the dog was clinically healthy, indicating a successful surgical treatment.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC240 artigos no totalmostrando 123

2026

Congenital mesoblastic nephroma: a single-center retrospective study.

Translational pediatrics
2026

Neuroblastoma Presenting as a Congenital Renal Mass in a Neonate: A Diagnostic Pitfall.

Children (Basel, Switzerland)
2026

[Pink-red discoloration in the diaper of a neonate].

Nederlands tijdschrift voor geneeskunde
2026

Relapsed rhabdoid tumours and other non-nephroblastoma childhood and adolescent kidney tumours: perspectives from the HARMONICA collaboration.

Nature reviews. Urology
2026

Mesoblastic nephroma in a young Entlebucher Mountain Dog.

Journal of comparative pathology
2025

SOX11 is frequently expressed in ETV6::NTRK3-rearranged infantile fibrosarcoma and congenital mesoblastic nephroma.

Virchows Archiv : an international journal of pathology
2025

Successful Salvage Treatment With Afatinib and Anti-PD-1 Combined Chemotherapy in a Pediatric Patient With Relapsed Cellular-Type Congenital Mesoblastic Nephroma Harboring an EGFR-KDD Mutation.

Pediatric blood & cancer
2025

Prenatal diagnosis and postnatal management of perinatal thoracoabdominopelvic tumors: multicenter experience.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
2025

Clinical and Pathologic features of 535 Patients with Congenital Mesoblastic Nephroma: A Report from the Children's Oncology Group.

Annals of surgery
2025

Primary Intrarenal Yolk Sac Tumor in a Child: A Case Report with Summary of Prior Published Cases.

Fetal and pediatric pathology
2025

Multi-Observer Study on Diagnostic Accuracy of Pediatric Renal Tumors Imaged with Higher-Harmonic-Generation Microscopy.

Cancers
2025

Adjunctive diagnostic tool for histopathological classification of congenital mesoblastic nephroma based in molecular genetic findings.

Journal of cancer research and clinical oncology
2025

Mesenchymal Neoplasms of the Kidney and Perinephric Soft Tissue.

Surgical pathology clinics
2025

Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers.

Nature reviews. Urology
2025

Coexisting Congenital Mesoblastic Nephroma and Lissencephaly: Unique Case Report with Pathological Analysis and Its Clinical Significance.

Biomedicines
2025

Paediatric renal tumours: an update on challenges and recent developments.

Virchows Archiv : an international journal of pathology
2024

Characterization of malignant kidney tumors in childhood by 18F-FDG PET/CT.

World journal of urology
2024

Congenital Mesoblastic Nephroma Mixed Subtype: A Case Report of a Rare Neonatal Tumor.

Cureus
2024

Cellular congenital mesoblastic nephroma with focal anaplasia, report of a case.

Histopathology
2024

The oncogenic fusion protein EML4-NTRK3 requires three salt bridges for stability and biological activity.

Heliyon
2024

Pediatric Fibromatosis Lacks the Internal Tandem Duplication of EGFR Seen in Congenital Mesoblastic Nephroma.

Genes, chromosomes & cancer
2024

Poor outcome in congenital mesoblastic nephroma with TPM3::NTRK1 fusion: a case report from multi-disciplinary treatment to molecular tumor board.

Translational pediatrics
2024

RAF1 gene fusions are recurrent driver events in infantile fibrosarcoma-like mesenchymal tumors.

The Journal of pathology
2024

Xanthogranulomatous Pyelonephritis in a Neonate Masquerading as Renal Mass.

Journal of Indian Association of Pediatric Surgeons
2024

Diagnostic magnetic resonance imaging characteristics of congenital mesoblastic nephroma: a retrospective multi-center International Society of Pediatric Oncology-Renal Tumor Study Group (SIOP-RTSG) radiology panel study.

Pediatric radiology
2023

A novel EML4-NTRK3 fusion in lung adenocarcinoma with dramatic response to entrectinib.

Journal of cancer research and therapeutics
2024

Imaging characterization of paediatric tumours with the neurotrophic tyrosine receptor kinase fusion transcript.

The British journal of radiology
2024

How to improve initial diagnostic accuracy of kidney tumours in childhood?-A non-invasive approach.

International journal of cancer
2024

Congenital Mesoblastic Nephroma Mimic Wilms Tumor on 18 F-FDG PET/CT and PET/MR.

Clinical nuclear medicine
2023

Case report of an infant with congenital mesoblastic nephroma leading to pulmonary metastasis.

SAGE open medical case reports
2023

A massive primary congenital mesoblastic nephroma was successfully managed through open total nephrectomy: a case report.

Annals of medicine and surgery (2012)
2023

A Pathogenic Germline BRCA1 Variant in a Patient With Cellular Congenital Mesoblastic Nephroma: A Case Report.

Cureus
2023

Report and follow-up on two new patients with congenital mesoblastic nephroma.

Italian journal of pediatrics
2023

Congenital Mesoblastic Nephroma: A Case Report.

JNMA; journal of the Nepal Medical Association
2023

Case report: Congenital mesoblastic nephroma.

International journal of surgery case reports
2022

Prenatal diagnosis and postnatal management of congenital mesoblastic nephroma: A case report and literature review.

Frontiers in pediatrics
2022

Infantile Congenital Mesoblastic Nephroma Leading to Multi-Systemic End-Organ Disease.

Cureus
2023

Congenital mesoblastic nephroma: review of current management and outcomes in a single centre.

ANZ journal of surgery
2023

Hypermethylation of RASSF1A gene in pediatric rhabdoid tumor of the kidney and clear cell sarcoma of the kidney.

Pediatric blood & cancer
2022

Use of Calcitonin for Hypercalcemia in a Premature Neonate With Congenital Mesoblastic Nephroma.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG
2022

Prenatal Course and Sonographic Features of Congenital Mesoblastic Nephroma.

Diagnostics (Basel, Switzerland)
2023

Epidemiologic and Clinical Outcomes of Pediatric Renal Tumors in Korea: A Retrospective Analysis of The Korean Pediatric Hematology and Oncology Group (KPHOG) Data.

Cancer research and treatment
2023

EGFR internal tandem duplications in fusion-negative congenital and neonatal spindle cell tumors.

Genes, chromosomes & cancer
2022

Non-Wilms' renal tumors in children: experience with 139 cases treated at a single center.

BMC urology
2022

Hematuria due to the congenital mesoblastic nephroma: A rare case report.

Asian journal of surgery
2022

Neonatal congenital mesoblastic nephroma that caused respiratory oncologic emergency early after birth: a case report.

BMC pediatrics
2022

Cellular congenital mesoblastic nephroma detected by prenatal MRI: a case report and literature review.

Translational pediatrics
2022

Imaging of Prenatal and Neonatal Intra-abdominal Genitourinary Tumors: a Review of the Literature.

Current urology reports
2022

Severe neonatal hypercalcemia revealing congenital mesoblastic nephroma: A case report and management of neonatal hypercalcemia: Severe neonatal hypercalcemia revealing congenital mesoblastic nephroma.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
2022

Infantile fibrosarcoma with an EGFR kinase domain duplication: Underlining a close relationship with congenital mesoblastic nephroma and highlighting a similar morphological spectrum.

Annals of diagnostic pathology
2022

Mesenchymal neoplasms with NTRK and other kinase gene alterations.

Histopathology
2021

Benign Renal Tumors in Pediatric Age Group: Retrospective Analysis.

Journal of Indian Association of Pediatric Surgeons
2022

ALK rearrangements in infantile fibrosarcoma-like spindle cell tumours of soft tissue and kidney.

Histopathology
2022

NTRK-Rearranged soft tissue neoplasms: A review of evolving diagnostic entities and algorithmic detection methods.

Cancer genetics
2021

Role of Cyclin D1 and BCOR Immunohistochemistry in Differentiating Clear Cell Sarcoma of Kidney From its Mimics.

Journal of pediatric hematology/oncology
2021

Congenital Bilateral Wilms Tumor: A Case Report.

Urology
2021

An unusual fusion gene EML4-ALK in a patient with congenital mesoblastic nephroma.

Genes, chromosomes & cancer
2021

Prenatal Diagnosis of Fetal Congenital Mesoblastic Nephroma and Neonatal Follow-up.

Journal of medical ultrasound
2021

[Imaging of renal tumors in children].

Der Radiologe
2021

Second Report of PDE10A-BRAF Fusion in Pediatric Spindle Cell Sarcoma With Infantile Fibrosarcoma-Like Morphology Suggesting PDE10A-BRAF Fusion Is a Recurrent Event.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
2021

[The clinicopathological features and research progress of congenital mesoblastic nephroma].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2021

Novel BRAF gene fusions and activating point mutations in spindle cell sarcomas with histologic overlap with infantile fibrosarcoma.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2021

NTRK fusions and Trk proteins: what are they and how to test for them.

Human pathology
2021

Prenatal diagnosis and postnatal management of congenital mesoblastic nephroma: Experience at a single center in China.

Prenatal diagnosis
2021

Prenatal diagnosis of fetal congenital mesoblastic nephroma by ultrasonography combined with MR imaging: A case report and literature review.

Medicine
2020

A systematic review and meta-analysis of neurotrophic tyrosine receptor kinase gene fusion frequencies in solid tumors.

Therapeutic advances in medical oncology
2021

Antenatally diagnosed kidney tumor: Answers.

Pediatric nephrology (Berlin, Germany)
2021

[Diagnosis and therapy of tumors with NTRK gene fusion].

Der Pathologe
2020

Imaging of solid congenital abdominal masses: a review of the literature and practical approach to image interpretation.

Pediatric radiology
2021

Imaging manifestations of congenital mesoblastic nephroma.

Clinical imaging
2020

Renal malignant tumor with the loss of INI1 expression and WT1 positive in a 3-year-old boy: a case report.

Translational andrology and urology
2020

Expanding Phenotype of Schimke Immuno-Osseous Dysplasia: Congenital Anomalies of the Kidneys and of the Urinary Tract and Alteration of NK Cells.

International journal of molecular sciences
2021

Papers presented at the fall 2020 Pediatric Urologic Oncology Work Group of the Societies of Pediatric Urology meetingPrenatally Diagnosed Solid Renal Mass.

Urology
2020

Incidence, treatment, and outcomes of primary and recurrent Non-Wilms renal tumors in children: Report of 109 patients treated at a single institution.

Journal of pediatric urology
2020

Congenital mesoblastic nephroma is characterised by kinase mutations including EGFR internal tandem duplications, the ETV6-NTRK3 fusion, and the rare KLHL7-BRAF fusion.

Histopathology
2020

Recurrent EGFR alterations in NTRK3 fusion negative congenital mesoblastic nephroma.

Practical laboratory medicine
2020

NTRK-rearranged mesenchymal tumours: diagnostic challenges, morphological patterns and proposed testing algorithm.

Pathology
2020

Diagnostic Utility of BCOR Antibody in Clear Cell Sarcomas of Kidney.

International journal of surgical pathology
2020

Lessons learned from the developmental origins of childhood renal cancer.

Anatomical record (Hoboken, N.J. : 2007)
2020

Congenital mesoblastic nephroma: a single-centre series.

Annals of the Royal College of Surgeons of England
2019

Prenatal diagnosis of congenital mesoblastic nephroma: a case with poor prognosis.

BMJ case reports
2019

Laparoscopic management of congenital mesoblastic nephroma- case report.

Urology case reports
2019

Re: Recurrent and Metastatic Congenital Mesoblastic Nephroma: Where Does the Evidence Stand?

The Journal of urology
2020

Unusual Case of Concurrent Retroperitoneal Congenital Infantile Fibrosarcoma and Cellular Type Congenital Mesoblastic Nephroma.

Journal of pediatric hematology/oncology
2019

The clinical presentation, imaging features and differential diagnoses of congenital Wilms tumour.

BMJ case reports
2019

Anaplastic sarcoma of the kidney: Case report and literature review.

Tzu chi medical journal
2019

Paraneoplastic disorders associated with miscellaneous neoplasms with focus on selected soft tissue and Undifferentiated/ rhabdoid malignancies.

Seminars in diagnostic pathology
2019

Neurotrophic tropomyosin or tyrosine receptor kinase (NTRK) genes.

Journal of clinical pathology
2019

TRK Fusion Cancers in Children: A Clinical Review and Recommendations for Screening.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2018

Congenital Mesoblastic Nephroma Presenting with Hematuria in a Neonate.

Journal of Nippon Medical School = Nippon Ika Daigaku zasshi
2018

A rare cause of neonatal hypertension: Congenital mesoblastic nephroma.

The Turkish journal of pediatrics
2018

Specific computed tomography imaging characteristics of congenital mesoblastic nephroma and correlation with ultrasound and pathology.

Journal of pediatric urology
2018

Estimated glomerular filtration rate after nephrectomy for Wilms tumor.

Pediatrics international : official journal of the Japan Pediatric Society
2018

Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants.

Nature communications
2018

Dramatic bone remodeling following larotrectinib administration for bone metastasis in a patient with TRK fusion congenital mesoblastic nephroma.

Pediatric blood & cancer
2018

Fetal biparametric MR imaging in the diagnosis of congenital mesoblastic nephroma.

Turkish journal of urology
2018

Evaluation of renal tumors in children.

Turkish journal of urology
2018

Use of Pretherapy Core Biopsy in the Diagnosis of Pediatric Renal Tumors.

Journal of Indian Association of Pediatric Surgeons
2018

ETV6-NTRK3 in congenital mesoblastic nephroma: A report of the SIOP/GPOH nephroblastoma study.

Pediatric blood & cancer
2017

Unusual Presentation of Metanephric Stromal Tumor in a Neonate.

Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology
2018

Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2017

Recurrent and metastatic congenital mesoblastic nephroma: where does the evidence stand?

Pediatric surgery international
2017

Cellular Congenital Mesoblastic Nephroma in a Newborn.

Journal of neonatal surgery
2017

[Solid pediatric tumors : A brief survey of the rarity cabinet].

Der Pathologe
2018

Targeting NTRK fusions for the treatment of congenital mesoblastic nephroma.

Pediatric blood & cancer
2017

Management of mixed type congenital mesoblastic nephroma: Case series and review of the literature.

Journal of neonatal-perinatal medicine
2017

Congenital Mesoblastic Nephroma Presenting With Refractory Hypertension in a Premature Neonate: A Case Study.

Neonatal network : NN
2017

Congenital mesoblastic nephroma 50 years after its recognition: A narrative review.

Pediatric blood & cancer
2017

Renal Tumors in Children Younger Than 12 Months of Age: A 65-Year Single Institution Review.

Journal of pediatric hematology/oncology
2017

BRAF exon 15 mutations in pediatric renal stromal tumors: prevalence in metanephric stromal tumors.

Human pathology
2016

[Congenital mesoblastic nephroma: a clinicopathologic analysis of 17 cases].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2016

The Value of Mitotic Count and Ki67 Proliferation Index in Congenital Mesoblastic Nephroma.

Fetal and pediatric pathology
2016

Cytological diagnosis of mesoblastic nephroma: A report of three cases with summary of prior published cases.

Diagnostic cytopathology
2016

Uncommon renal tumors in children: A single center experience.

Journal of Indian Association of Pediatric Surgeons
2016

Congenital mesoblastic nephroma: a study of 19 cases using immunohistochemistry and ETV6-NTRK3 fusion gene rearrangement.

Pathology
2015

Mixed subtype of congenital mesoblastic nephroma with poor evolution: a case report and literature review.

Radiologia brasileira
2015

Growing Renal Mass: Lessons Learned on the Road From an Atypical Presentation to Successful Therapy.

Urology case reports
2016

Congenital Mesoblastic Nephroma Presenting With Hematuria in a Neonate: A Case Report.

Urology
2016

Congenital mesoblastic nephroma: Its diverse clinical features - A literature review with a case report.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
2015

Prenatal diagnosis of congenital mesoblastic nephroma.

Obstetrics & gynecology science
2015

Congenital mesoblastic nephroma with focal anaplastic lesion.

Pathology international
2015

Intestinal congenital/infantile fibrosarcoma: a new clinico-pathological entity?

Pediatric surgery international
2015

Diffuse and strong cyclin D1 immunoreactivity in clear cell sarcoma of the kidney.

Histopathology
Ver todos os 240 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Nefroma mesoblástico congênito.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Nefroma mesoblástico congênito e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ainda não achamos doenças com sintomas parecidos o suficiente.

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

É uma neoplasia maligna congênita infantil de baixo grau que tem origem no rim e é formada por células fibroblásticas. A grande maioria dos diagnósticos acontece ainda no primeiro ano de vida do paciente.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

5 publicações do grafo RarasNet (PubMed) · 6 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. ORPHA:2665
    Orphanet
  2. GARD:1493
    GARD (NIH)
  3. Q18556472
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Nefroma mesoblástico congênito. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/nefroma-mesoblastico-congenito

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Nefroma mesoblástico congênito

ORPHA:2665 · MONDO:0017043
CID-10
D41.0 · Neoplasia de comportamento incerto ou desconhecido do rim
CID-11
Ensaios
2 ativos
Início
Infancy, Neonatal
MedGen
UMLS
C1332965
EuropePMC
Wikidata
Papers 10a

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Indexação biomédica
fonte: MeSH (NLM)
Dado público estruturado
fonte: Wikidata
Rara